Post X-Waiver Substance Use Disorder Training Module 2: SBIRT and Talking to Patients

Description

Register now for this online, self-guided course!

This module will provide an overview of screening tools for substance use disorder and mental health disorders in primary care, as well as the brief intervention options which providers can use after potential SUD has been diagnosed and assessed. It will educate viewers on the importance of screening and the benefits that screening in primary care have on patient health and the health of the community overall. The content then discusses how to communicate treatment options with patients using non-stigmatizing language and how to effectively counsel patients, as well as their families and friends, on harm reduction measures like having access to naloxone and safe storage of opioids.

Approximate time to complete the course: 1 hour
Learner content includes: video and corresponding course handouts
Participants have unlimited time to complete this course and access course materials

This training module is part of a training suite that has been developed in accordance with the recommendations from the DEA and SAMHSA for the Medication Access and Training Expansion (MATE) Act. This requirement applies to physicians, physician assistants, nurse practitioners, podiatrists, dentists, and other practitioners that prescribe controlled substances who are applying for or renewing their DEA license after June 27, 2023.

Click here for more information and a full listing of modules available.


MAHEC engages in evaluation activities to better understand the impact of our programs. By registering for this course, you agree that we may use your personal information in evaluative research regarding this program. Any reports published will be de-identified and reported in aggregate format.

With Support From

Target Audience

This program is recommended for physicians, physician assistants, nurse practitioners, podiatrists, dentists, and other practitioners that prescribe controlled substances.

Objectives

• Consider the importance of screening in primary care, especially for substance use disorders
• Analyze the various validated screening tools for substance use disorders and mental health disorders for youths and adults
• Recognize that non-stigmatizing screening is cost effective and improves health
• Describe the different types of interventions for SUD and when to treat SUD
• Assess if SUD can be treated effectively in primary care or a higher level of care is appropriate
• Recognize the importance of using non-stigmatizing language with patients
• Demonstrate ability to effectively counsel patients and their families on the risks of substance use and how to decrease risk using harm reduction, including naloxone prescribing

Faculty

• Blake Fagan, MD